CPRX   $21.92  3.45% Market Closed After Close 22.26 1.55%

Catalyst Pharmaceuticals Inc
Last Events:

2023-08-09 Signal in Stochastic changed from bearish to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: main and signal line crossing.

2023-08-09 Signal in EMA100 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

2023-08-06 Trend pattern changed from симметричный треугольник to восходящий треугольник.

2023-08-06 Signal in MACD changed from bearish reversal to bullish recovery. Oscillator MACD is in the positive territory it crossed the signal line from the bottom and grows. These factors mean that the market confirms the tendency to growth. Last signal: main and signal line crossing.

2023-08-05 Signal in Stochastic changed from bullish weakening to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

2023-08-05 Signal in MACD changed from bullish weakening to bearish reversal. Oscillator MACD is in the positive territory it crossed the signal line from the top and falls. These factors mean that the market confirms the end of the upward trend. Last signal: main and signal line crossing.

2023-08-05 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

2023-08-04 Signal in Stochastic changed from bullish to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: main and signal line crossing.


Current temperature: 22.32
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 24.06
High with % probability:
Analyst Recommendations:
Number of estimates 8
Target Price Mean 32.25
Mean unverified/preliminary 32.25 / 32.25
Target Price Low / High 28.00 / 38.00
Median / STD DEV 31.00 / 3.62
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None ActivelyBuy ActivelyBuy
rsi Sell ActivelyBuy ActivelyBuy
macd None None None
stoch None None None
ma20 Buy ActivelyBuy None
ma50 None None None
ma100 None ActivelyBuy ActivelyBuy
Candlestick PatternNov. 20, 2024 After Bottom Gap Up - pattern is a made up of five candlesticks. Pattern appears on a downtrend. The pattern begins with a black candlestick. The next two days are also black days. The third day gaps down and opens below the close of the second day. The fifth day is a strong white with a gap above the previous day’s close. Considered to be a bullish reversal pattern.
ISIN US14888U1016
ceo Mr. Richard John Daly M.B.A.
Website https://www.catalystpharma.com
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.